December 08, 2021

EPA Terminates COVID-19 Policies for Disinfectant Notification Mandates

You've Reached Your
Free Article Limit This Month
Register for free to get unlimited access to all OnPractice content.
Register Now

On Sept. 15, EPA issued a Notice to Manufacturers, Producers, Formulators and Registrants of Pesticide Product announcing plans to reverse measures that increased the availability of disinfectants that can kill COVID-19. An EPA press release accompanying the Notice states: "[i]n 2020, EPA introduced regulatory flexibilities to ensure that critical antimicrobial products remained available as the country responded to the COVID-19 public health emergency. As supply chains have stabilized and disinfectant products expected to kill SARS-CoV-2 (the virus that causes COVID-19) have become consistently available to consumers, the agency has determined that this flexibility is no longer needed…" EPA is granting a one-year grace period, until Sept. 15, 2022, before the termination takes effect.

In spite of flexibility originally granted under 2020 FIFRA policies, EPA has been pushing companies to file amendments that would formalize any supply changes they made under the temporary policy. The Notice states, "[s]ince the Fall of 2020, EPA has also been encouraging registrants to amend their registrations by either submitting a notification or amendment, as applicable to make permanent any changes made using the temporary amendments. Further, EPA is not aware that the supply chain issues that justified the issuance of the temporary amendment continue to persist…"

Specifically, EPA is terminating the policy that allowed makers of disinfectants already registered to the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) "List N" of products certified to kill the coronavirus, to quickly seek new sources of certain active ingredients when faced with supply chain disruptions, "without having to first apply for and receive EPA approval." In April 2020, EPA expanded that waiver to allow approved disinfectant manufacturers that use any of eight active ingredients to source the substances from any source without first seeking EPA approval. Then, in May 2020, the agency added isopropyl alcohol as a ninth active ingredient that qualified for flexible sourcing.

In the Sept. 15 Notice, EPA "acknowledges that registrants have made changes in their supply chains based on the temporary amendment, and that registrants require time to make the temporary changes permanent," and writes that the termination will take effect on Sept. 15, 2022. The Notice goes on to state, "[a]fter that date, registrants will not be able to release for shipment formulations produced under the conditions of the temporary amendment without first complying with the registration requirements that were in place prior to the issuance of the temporary amendments…"

Companies that have been taking advantage of EPA's temporary policies will need to evaluate their operations and ensure that they have obtained necessary EPA approvals or changed their business practices by Sept. 15, 2022. Please contact a Clark Hill Environmental & Natural Resources attorney with any questions concerning the Notice or its potential impacts on your business.

ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.

More From Clark Hill, PLC

What the California Environmental Quality Act Means for Cannabis Operators in the Golden State

By Steven L. Hoch Clark Hill, PLC March 22 , 2022

Cannabis is big business in California.

EPA Proposes Updates to the Hazardous Air Pollutant Copper Smelting Rules

By Danielle M. Hazeltine Clark Hill, PLC March 22 , 2022

On Jan. 11, EPA proposed more stringent National Emissions Standards for Hazardous Air Pollutants (NESHAPs) that apply to both major and area source primary copper smelters.

Investing in State Law Compliant Cannabis Businesses: Part 2 - Diving Deeper

By Sander C. Zagzebski Clark Hill, PLC March 21 , 2022

In Part 1 of this two-part series, we addressed the high-level concerns that a new investor should consider in making an investment in a state legal cannabis company. In this follow up, we address some of the more nuanced issues that investors should consider before deciding to invest in a specific cannabis company.

More From COVID-19

Schedule A I-140: Fast-Track Green Card for Nurses and Physical Therapists

By Caterina Cappellari Greenberg Traurig May 26 , 2023

Most employment-based permanent residency applications require the applicant to go through the PERM labor certification process where the U.S. Department of Labor (DOL) certifies that there are not sufficient U.S. workers able, available, and qualified to fill a position.

Challenging OSHA Violations at Occupational Safety and Health Review Commission Is Worth the Effort

By Melanie L. Paul Jackson Lewis P.C. May 26 , 2023

It is more important than ever that employers understand the serious long-term, non-monetary consequences of settling or accepting Occupational Safety and Health Administration (OSHA) citations.

HHS Releases Ownership Data of Medicare-Certified Hospices and Home Health Agencies

By Gregory E. Fosheim McDermott Will & Emery May 24 , 2023

On April 20, 2023, the US Department of Health and Human Services (HHS) made ownership data of all Medicare-certified hospices and home health agencies publicly available for the first time.

Featured Stories